NL191690C - 3-(1-(heterocyclyl-1-carbonyl)alkylcarbamoyl)-oxiran-2-carbonzuren of alkylesters daarvan en farmaceutisch preparaat dat een dergelijke verbinding omvat. - Google Patents

3-(1-(heterocyclyl-1-carbonyl)alkylcarbamoyl)-oxiran-2-carbonzuren of alkylesters daarvan en farmaceutisch preparaat dat een dergelijke verbinding omvat.

Info

Publication number
NL191690C
NL191690C NL8201509A NL8201509A NL191690C NL 191690 C NL191690 C NL 191690C NL 8201509 A NL8201509 A NL 8201509A NL 8201509 A NL8201509 A NL 8201509A NL 191690 C NL191690 C NL 191690C
Authority
NL
Netherlands
Prior art keywords
oxiran
alkylcarbamoyl
heterocyclyl
carbonyl
compound
Prior art date
Application number
NL8201509A
Other languages
English (en)
Other versions
NL191690B (nl
NL8201509A (nl
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of NL8201509A publication Critical patent/NL8201509A/nl
Publication of NL191690B publication Critical patent/NL191690B/nl
Application granted granted Critical
Publication of NL191690C publication Critical patent/NL191690C/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/48Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL8201509A 1981-04-10 1982-04-08 3-(1-(heterocyclyl-1-carbonyl)alkylcarbamoyl)-oxiran-2-carbonzuren of alkylesters daarvan en farmaceutisch preparaat dat een dergelijke verbinding omvat. NL191690C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56053116A JPS57169478A (en) 1981-04-10 1981-04-10 Piperazine derivative
JP5311681 1981-04-10

Publications (3)

Publication Number Publication Date
NL8201509A NL8201509A (nl) 1982-11-01
NL191690B NL191690B (nl) 1995-11-01
NL191690C true NL191690C (nl) 1996-03-04

Family

ID=12933824

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8201509A NL191690C (nl) 1981-04-10 1982-04-08 3-(1-(heterocyclyl-1-carbonyl)alkylcarbamoyl)-oxiran-2-carbonzuren of alkylesters daarvan en farmaceutisch preparaat dat een dergelijke verbinding omvat.

Country Status (17)

Country Link
US (2) US4507297A (nl)
JP (1) JPS57169478A (nl)
KR (1) KR880000786B1 (nl)
AU (1) AU545938B2 (nl)
BR (1) BR8202085A (nl)
CA (1) CA1166637A (nl)
CH (1) CH650504A5 (nl)
DD (1) DD202567A5 (nl)
DE (1) DE3212882A1 (nl)
ES (2) ES511174A0 (nl)
FR (1) FR2503709A1 (nl)
GB (1) GB2098204B (nl)
HU (1) HU189574B (nl)
IT (1) IT1156459B (nl)
MX (1) MX7583E (nl)
NL (1) NL191690C (nl)
SU (1) SU1318161A3 (nl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6087277A (ja) * 1983-10-19 1985-05-16 Taisho Pharmaceut Co Ltd 光学活性トランス−エポキシコハク酸ジアルキルエステルの製造法
FR2680508B1 (fr) * 1991-08-20 1995-03-03 Adir Nouveaux composes amidiques des 1-(alcoxybenzyl)piperazines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2062943B1 (es) * 1993-03-23 1995-11-16 Uriach & Cia Sa J Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
US5556853A (en) * 1993-10-29 1996-09-17 Takeda Chemical Industries, Ltd. Epoxysuccinic acid derivatives
US5935959A (en) * 1995-07-13 1999-08-10 Senju Pharmaceutical Co., Ltd. Piperazine derivatives and use as cysteine inhibitors
US5733911A (en) * 1996-01-26 1998-03-31 Hitachi Chemical Co., Ltd. Method for inducing death of neoplastic cells using piperazne derivatives
JP4336039B2 (ja) * 1997-09-04 2009-09-30 日本ケミファ株式会社 エポキシコハク酸アミド誘導体
US6458781B1 (en) 1998-04-27 2002-10-01 David Thomas Connor Substituted diarylalkyl amides as calcium channel antagonists
US20090221603A1 (en) * 2005-12-19 2009-09-03 Hassan Pajouhesh Heterocyclic amide derivatives as calcium channel blockers
EP2029135A4 (en) * 2006-06-13 2011-08-17 Univ Leland Stanford Junior EPOXY HEMMER OF CYSTONE PROTEASES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2963482A (en) * 1957-09-09 1960-12-06 Lilly Co Eli Bis-epoxypropyldiamines
US2963483A (en) * 1958-12-22 1960-12-06 Union Carbide Corp Nu-glycidylpiperazine and method of making it
US4032567A (en) * 1972-02-16 1977-06-28 Schering Aktiengesellschaft Triiodoisophthalic acid monoamino acid amides, process for the preparation thereof, and use thereof as x-ray contrast media
GB1595168A (en) * 1977-03-03 1981-08-12 Taisho Pharmaceutical Co Ltd Expoxysuccinic acid derivatives
JPS5547668A (en) * 1978-09-30 1980-04-04 Taisho Pharmaceut Co Ltd Epoxysuccinamic acid
JPS55115878A (en) * 1979-02-27 1980-09-06 Taisho Pharmaceut Co Ltd Epoxysuccinic acid derivative
JPS55153778A (en) * 1979-05-17 1980-11-29 Taisho Pharmaceut Co Ltd Epoxysuccinylamino acid derivative
JPS58126879A (ja) * 1982-01-25 1983-07-28 Nippon Chemiphar Co Ltd 光学活性なピペラジン誘導体ならびに心筋梗塞の予防および治療剤

Also Published As

Publication number Publication date
NL191690B (nl) 1995-11-01
AU545938B2 (en) 1985-08-08
KR880000786B1 (ko) 1988-05-09
FR2503709A1 (fr) 1982-10-15
JPH0154349B2 (nl) 1989-11-17
IT1156459B (it) 1987-02-04
GB2098204A (en) 1982-11-17
CH650504A5 (de) 1985-07-31
ES8402288A1 (es) 1984-01-16
DE3212882A1 (de) 1982-10-28
SU1318161A3 (ru) 1987-06-15
KR830010106A (ko) 1983-12-26
FR2503709B1 (nl) 1985-03-22
DE3212882C2 (nl) 1991-02-07
DD202567A5 (de) 1983-09-21
MX7583E (es) 1989-11-30
JPS57169478A (en) 1982-10-19
ES525245A0 (es) 1985-07-16
CA1166637A (en) 1984-05-01
ES511174A0 (es) 1984-01-16
IT8267485A0 (it) 1982-04-09
GB2098204B (en) 1984-08-15
ES8506304A1 (es) 1985-07-16
US4596803A (en) 1986-06-24
BR8202085A (pt) 1983-03-22
HU189574B (en) 1986-07-28
AU8227182A (en) 1982-10-14
NL8201509A (nl) 1982-11-01
US4507297A (en) 1985-03-26

Similar Documents

Publication Publication Date Title
NL193457B (nl) Benzoheterocyclische verbindingen en farmaceutisch preparaat dat een dergelijke verbinding bevat.
IT8448873A0 (it) Composizione per rivestimento enterico di compresse farmaceutiche esimili
DE68908788D1 (de) Derivate von p-substituierten Phenylestern von Pivaliksäure.
IS1307B6 (is) Aðferð til að framleiða lyfjablöndu
IT7830933A0 (it) Composizione farmaceutica ad azione prolungata contenente acidi biliari.
FI822683A0 (fi) Inert fyllnadsmaterial foer farmaceutiska kompositioner
NL191690C (nl) 3-(1-(heterocyclyl-1-carbonyl)alkylcarbamoyl)-oxiran-2-carbonzuren of alkylesters daarvan en farmaceutisch preparaat dat een dergelijke verbinding omvat.
FI793261A (fi) Farmaceutisk komposition som innehaoller 3,4-dihydro-3-oxo-2-kinoxaliner
IT1142014B (it) Formulazioni a lento rilascio di ferormoni maccone
IL61945A0 (en) 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them
NZ187674A (en) 2-(4-chlorophenyl)-methyl-5-benzoxazolylacetic acid and pharmaceutical compositions
DK41685D0 (da) Aminoalkanphosphonsyrer og derivater deraf til anvendelse som fungicider
DE2861595D1 (en) Pharmaceutical composition comprising a 5-aroyl-1-c1-5 alkyl-pyrrole-2-acetic acid compound and acetaminophen or acetylsalicylic acid
MC1371A1 (fr) Preparations pharmaceutiques
MC1372A1 (fr) Preparations pharmaceutiques
DK295079A (da) Farmaceutisk komposition indeholdende trimethoprim og n-ethyl-gamma-pyridon-3-carboxylsyrederivater
DK157672C (da) Fremgangsmaade til fremstilling af 2,4-dichlor- eller 2-methyl-4-chlorphenoxyeddikesyre og alfa-2,4-dichlor- eller alfa-2-methyl-4-chlorphenoxypropionsyre
FR2614788B1 (fr) Composition pharmaceutique a activite antiseptique
IT1198400B (it) Composti erbicidi derivati da acidi fenossi benzoici
BE891013A (fr) Compositions pharmaceutique
DK41281A (da) 2-nitro-5-(substitueret phenoxy)-benzoatestere af hydroxyalkansyrer og derivater deraf til anvendelse som herbicider
IT1208432B (it) Composizioni farmaceutiche
IT8249072A0 (it) Composizioni farmaceutiche
FR2509611B1 (fr) Nouvel agent anti-acide et composition pharmaceutique le contenant
DE3261448D1 (en) Derivative of acetylsalicylic acid having an analgetic, antipyretic, antiphlogistic and bronchosecretolytic activity

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 20001101